Reports > Life Sciences > Cell Banking Outsourcing Market Report
Cell Banking Outsourcing Market Size, Share, Industry Trends and Forecast to 2033
This report provides an in-depth analysis of the Cell Banking Outsourcing market, including market size forecasts and insights from 2023 to 2033, along with trends, regional breakdowns, and company profiles for key industry players.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $3.50 Billion |
| CAGR (2023-2033) | 6.2% |
| 2033 Market Size | $6.48 Billion |
| Top Companies | Lonza Group, CryoBanking International, Source BioScience, STEMCELL Technologies |
| Last Modified Date | 15 Nov 2024 |
Cell Banking Outsourcing Market Report (2023 - 2033)
Cell Banking Outsourcing Market Overview
What is the Market Size & CAGR of Cell Banking Outsourcing market in 2023?
Cell Banking Outsourcing Industry Analysis
Cell Banking Outsourcing Market Segmentation and Scope
Request a custom research report for industry.
Cell Banking Outsourcing Market Analysis Report by Region
Europe Cell Banking Outsourcing Market Report:
The European market for cell banking outsourcing is currently valued at $0.90 billion and is expected to reach approximately $1.66 billion by 2033. The growth is bolstered by stringent regulations governing cell storage and handling, coupled with rising investments from biotechnology firms seeking innovative solutions.Asia Pacific Cell Banking Outsourcing Market Report:
The Asia Pacific region, valued at $0.73 billion in 2023, is expected to grow to $1.35 billion by 2033. The rise in biotechnology initiatives and increased funding in stem cell research in countries like Japan and China are key growth drivers. Additionally, the growing number of research institutions and the adoption of advanced storage technologies in the region are propelling market expansion.North America Cell Banking Outsourcing Market Report:
North America holds the largest market share, with a projected increase from $1.20 billion in 2023 to $2.22 billion by 2033. The region is characterized by a strong presence of key players, a robust regulatory environment, and significant investment in R&D, particularly in cellular therapies and biobanking technologies.South America Cell Banking Outsourcing Market Report:
In South America, the cell banking outsourcing market is forecasted to increase from $0.29 billion in 2023 to $0.55 billion by 2033. Growth in this region is attributed to increased healthcare spending and improved access to advanced biobanking services, particularly in Brazil and Argentina, where partnerships with global players are emerging.Middle East & Africa Cell Banking Outsourcing Market Report:
The Middle East and Africa market is set to rise from $0.38 billion in 2023 to $0.70 billion by 2033. The expansion is supported by increases in awareness of stem cell research and therapy in GCC countries, alongside investment in healthcare infrastructure and biobanking facilities.Request a custom research report for industry.
Cell Banking Outsourcing Market Analysis By Service Type
Global Cell Banking Outsourcing Market, By Service Type Market Analysis (2023 - 2033)
The major service types in the cell banking outsourcing market include automated storage systems and manual storage systems. Automated storage systems accounted for a significant market share in 2023 due to their efficiency and reliability. The market for automated storage systems is projected to grow from $2.86 billion in 2023 to $5.30 billion by 2033, demonstrating strong adoption in biobanking operations. In contrast, manual storage systems represented a smaller segment, with expected growth from $0.64 billion to $1.18 billion, highlighting the gradual shift toward automation.
Cell Banking Outsourcing Market Analysis By Expertise Area
Global Cell Banking Outsourcing Market, By Expertise Area Market Analysis (2023 - 2033)
Segmented by expertise area, the market features Hematopoietic Stem Cells, Mesenchymal Stem Cells, and Induced Pluripotent Stem Cells. Hematopoietic stem cells dominate the market, projected to rise from $2.37 billion in 2023 to $4.39 billion by 2033. This segment's growth is driven by increasing research and clinical applications in regenerative medicine. Mesenchymal stem cells are similarly significant, extending from $0.89 billion to $1.65 billion, while Induced Pluripotent Stem Cells, though smaller in market size, are gaining traction due to innovations in regenerative therapies.
Cell Banking Outsourcing Market Analysis By End User Industry
Global Cell Banking Outsourcing Market, By End-User Industry Market Analysis (2023 - 2033)
The end-user industries for cell banking outsourcing include pharmaceuticals, biotechnology, research institutes, and academic institutions. Pharmaceuticals lead with a size of $1.84 billion in 2023, projected to grow to $3.40 billion by 2033. This reflects the heavy reliance on cell banking for drug development processes. Biotechnology firms follow with growth from $0.83 billion to $1.55 billion, indicating an expanding intersection between biotechnology advancements and cellular therapies.
Cell Banking Outsourcing Market Analysis By Storage Type
Global Cell Banking Outsourcing Market, By Storage Type Market Analysis (2023 - 2033)
Storage types include Liquid Nitrogen Tanks and Vapor Phase Storage. Liquid Nitrogen Tanks dominate with a share of 81.79%, projected to grow from $2.86 billion to $5.30 billion by 2033, while Vapor Phase Storage, with an 18.21% share, is expected to rise from $0.64 billion to $1.18 billion. The efficiency of liquid nitrogen storage in preserving biological materials under ultra-low temperatures fuels its continued preference among operators.
Cell Banking Outsourcing Market Analysis By Technology
Global Cell Banking Outsourcing Market, By Technology Market Analysis (2023 - 2033)
In terms of technology, the market reflects ongoing advancements in cellular preservation techniques, including cryopreservation technology and automated storage solutions. Companies are increasingly adopting innovative technological solutions to meet the regulatory requirements of biobanking, as well as enhance operational standards. This sector is projected to witness continuous evolution, ensuring optimized preservation and retrieval of biological samples.
Cell Banking Outsourcing Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Cell Banking Outsourcing Industry
Lonza Group:
Lonza is a global leader in bioproducts and contract manufacturing, providing comprehensive services for cell banking and regenerative medicine.CryoBanking International:
A prominent player in the cell banking market, CryoBanking specializes in umbilical cord blood banking, providing critical services for stem cell storage.Source BioScience:
Source BioScience offers a range of bioservices, including cell line banking and biobanking solutions for research and clinical use.STEMCELL Technologies:
STEMCELL Technologies focuses on developing comprehensive tools for cell culture, differentiation, and storage, serving the research and clinical communities.We're grateful to work with incredible clients.
